AR and breast cancer: In MCF7, AR, the cognate receptor of dihydrotestosterone (DHT), an androgen that decreases the estradiol-dependent growth of breast cancer cells [7], [19], [20], was 6.8 times less expressed than ERα, whereas the difference is only 1.5 times in T47D.